Person profile

Public information reviewed

Felix J. Baker, Ph.D.

Board role

Director · BICYCLE THERAPEUTICS PLC (NASDAQ: BCYC)

Board role

Director · Kymera Therapeutics, Inc. (NASDAQ: KYMR)

Board role

Director · Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA)

BICYCLE THERAPEUTICS PLC (NASDAQ: BCYC)

Director · Current mandate

Director
FollowSave PDF
More
Reports & analysis (Check report directory)Alpha Eval
Evidence records
8
Profile ownership
Not yet claimed
Record reviewed
May 16, 2026
View evidence

Structured intelligence coverage

Structured records are temporarily unavailable. The published profile and its source ledger remain accessible.

Identity checks do not refresh the age of governance evidence. Open a record for its source date and review state.

Profile

Identity, professional record and current appointments.

Overview

Professional record at a glance

A concise summary of information supported by the cited public sources. Missing information is treated as unknown, not as a negative finding.

Current roles
33 current organizations shown on this profile
Board positions
33 supported by public sources, 0 supplied by the profile owner
Committee roles
1Roles supported by the sources cited on this profile
Qualifications
Not establishedNo qualification is currently confirmed by the cited sources

Professional narrative

About

Managing Member of Baker Bros. Advisors LP (founded 2000). Lead Independent Director since 2015. Holds B.S. and Ph.D. in Immunology from Stanford University and completed two years of medical school. Serves on boards of Kodiak Sciences, IGM Biosciences, Kymera Therapeutics, and Bicycle Therapeutics.

Sources are shown with the information they support.

Current roles

Appointments & responsibilities

Board appointments

Governance

Board appointments, committee responsibilities and disclosed relationships.

Committee appointments across companies · Temporarily unavailable

Structured records for this section are unavailable. This does not establish that no records exist. Published profile sources remain in Evidence & History.

Board and advisory record

Board service

Sources are shown with each role, education record, or credential.

Director

Kymera Therapeutics, Inc.

2024-01-01 · current

Confirmed by public sourceView source

Director

BICYCLE THERAPEUTICS PLC

2024-01-01 · current

Confirmed by public sourceView source

Director

Kiniksa Pharmaceuticals International, plc

2015-01-01 · current

Confirmed by public sourceView source

Connections

Explore the roles, education and affiliations published in this record.

BICYCLE THERAPEUTICS PLC

Open BICYCLE THERAPEUTICS PLC profile →

Director at BICYCLE THERAPEUTICS PLC

2024-01-01 → End not stated

current · source reported

Observed: 2026-09-25

BICYCLE THERAPEUTI…BICYCLE THERAPEUTICS PLCKiniksa Pharmaceut…Kiniksa Pharmaceuticals International, plcKymera Therapeutic…Kymera Therapeutics, Inc.Felix J. Baker, Ph…

Dashed lines mark past roles. Select a connection to see its dates and sources.

Relationship map

Connected through the public record

Direct relationships from verified facts and published résumé records. Private connections are excluded.

Direct public links only

Only published affiliations are shown here. Private relationships require authorized access.

Experience

Career history, education, credentials and public contributions.

Published record

Featured coverage

Selected publications and public sources used to establish this profile. Inclusion records provenance; it is not an endorsement.

Source 1 · Sec FilingBCYC DEF 14A director slateSupports Board role, Committee assignments.Open sourceSource 2 · Sec FilingKNSA DEF 14A director slateSupports AI and ML experience, Board role, Committee assignments, Cybersecurity experience, Technology background.Open sourceSource 3 · Sec ProxyPublic profile sourceSupports Director at Kymera Therapeutics, Inc. (NASDAQ: KYMR).Open source

Basis

Identifiers, sources, dates and record limitations.

Identifiers

Alpha ID
alpha:person:felix-j-baker-ph-d
Record version
public-0

Published evidence records

8 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. BCYC DEF 14A director slate

    sec filing · Source published: Apr 22, 2026 · Retrieved: May 15, 2026

    Supports 2 claims
    • Board role: Board role: Chair · Claim reviewed: May 15, 2026
    • Committee assignments: Committee assignments: Nominating/Governance · Claim reviewed: May 16, 2026

  2. Open source

    sec proxy · Source published: Apr 22, 2026 · Retrieved: Apr 24, 2026

    Supports 1 claim
    • Professional Role: Director at BICYCLE THERAPEUTICS PLC · Claim reviewed: May 16, 2026

  3. KNSA DEF 14A director slate

    sec filing · Source published: Apr 16, 2026 · Retrieved: May 16, 2026

    Supports 5 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Board role: Board role: Lead Independent Director · Claim reviewed: May 16, 2026
    • Committee assignments: Committee assignments: Nominating/Governance · Claim reviewed: May 16, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 16, 2026

  4. Open source

    sec proxy · Source published: Apr 16, 2026 · Retrieved: Apr 24, 2026

    Supports 1 claim
    • Professional Role: Director at Kiniksa Pharmaceuticals International, plc · Claim reviewed: May 16, 2026

  5. Open source

    sec proxy · Source published: Apr 29, 2025 · Retrieved: Jul 12, 2026

    Supports 1 claim
    • Professional Role: Director at Kymera Therapeutics, Inc. · Claim reviewed: May 16, 2026

  6. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of Kymera Therapeutics, Inc. · Claim reviewed: May 16, 2026

  7. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of BICYCLE THERAPEUTICS PLC · Claim reviewed: May 16, 2026

  8. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of Kiniksa Pharmaceuticals International, plc · Claim reviewed: May 16, 2026

Sources

Sources and published information

Each item links to the public source used to support it. When sources disagree, the item is clearly marked for review.

AI and ML experience · Source reportedAI and ML experience: not identified in the cited filing1 source
Verification
Source reported
Confidence
72%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Board membership · Source reportedServes on the board of BICYCLE THERAPEUTICS PLC1 source
Verification
Source reported
Confidence
Not stated
Last reviewed
Not stated
Board membership · Source reportedServes on the board of Kiniksa Pharmaceuticals International, plc1 source
Verification
Source reported
Confidence
Not stated
Last reviewed
Not stated
Board membership · Source reportedServes on the board of Kymera Therapeutics, Inc.1 source
Verification
Source reported
Confidence
Not stated
Last reviewed
Not stated
Board role · Source reportedBoard role: Chair1 source
Verification
Source reported
Confidence
92%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Board role · Source reportedBoard role: Lead Independent Director1 source
Verification
Source reported
Confidence
92%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Committee assignments · CorroboratedCommittee assignments: Nominating/GovernanceSupported by 2 public records2 sources
Verification
Corroborated
Confidence
88%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Cybersecurity experience · Source reportedCybersecurity experience: not identified in the cited filing1 source
Verification
Source reported
Confidence
72%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Technology background · Source reportedTechnology background: not identified in the cited filing1 source
Verification
Source reported
Confidence
72%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

View all sources8 records
  1. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

    Supports: Board role · Committee assignments

  2. https://www.sec.gov/Archives/edgar/data/1761612/000110465926046806/bcyc-20260617xdef14a.htm

    Sec Proxy · Tier not stated · Reviewed Apr 24, 2026

    Supports: Director at BICYCLE THERAPEUTICS PLC (NASDAQ: BCYC)

  3. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

    Supports: AI and ML experience · Board role · Committee assignments · Cybersecurity experience · Technology background

  4. https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm

    Sec Proxy · Tier not stated · Reviewed Apr 24, 2026

    Supports: Director at Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA)

  5. https://www.sec.gov/Archives/edgar/data/1815442/000119312525103767/d922602ddef14a.htm

    Sec Proxy · Tier not stated · Reviewed Jul 12, 2026

    Supports: Director at Kymera Therapeutics, Inc. (NASDAQ: KYMR)

  6. https://www.sec.gov/Archives/edgar/data/1815442/000119312525103767/d922602ddef14a.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership

  7. https://www.sec.gov/Archives/edgar/data/1761612/000110465926046806/bcyc-20260617xdef14a.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership

  8. https://www.sec.gov/Archives/edgar/data/1730430/000110465926044410/knsa-20260519xdef14a.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership